|Partial Close, 8/2009 ||$1.69M|
|Series B, 1/2014 |
Black Horse Investments
|Debt, 4/2013 ||$750k|
Promentis Pharmaceuticals Inc. discover, develop and market new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals Inc. was founded in 2006 and is based in Milwaukee, Wisconsin.